Pages that link to "Q38961152"
Jump to navigation
Jump to search
The following pages link to The antimicrobial susceptibility of Pseudomonas pseudomallei. Emergence of resistance in vitro and during treatment (Q38961152):
Displaying 50 items.
- Involvement of the efflux pumps in chloramphenicol selected strains of Burkholderia thailandensis: proteomic and mechanistic evidence (Q21089981) (← links)
- Molecular phylogeny of Burkholderia pseudomallei from a remote region of Papua New Guinea (Q21560842) (← links)
- Melioidosis: epidemiology, pathophysiology, and management (Q24522461) (← links)
- Trimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trial (Q24599933) (← links)
- Dosing regimens of cotrimoxazole (trimethoprim-sulfamethoxazole) for melioidosis (Q24651516) (← links)
- Management of melioidosis (Q28245689) (← links)
- An improved selective culture medium enhances the isolation of Burkholderia pseudomallei from contaminated specimens (Q28299122) (← links)
- Burkholderia pseudomallei isolates from Sarawak, Malaysian Borneo, are predominantly susceptible to aminoglycosides and macrolides (Q28300674) (← links)
- Growing Burkholderia pseudomallei in biofilm stimulating conditions significantly induces antimicrobial resistance (Q28472874) (← links)
- Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis (Q31876656) (← links)
- BpeAB-OprB, a multidrug efflux pump in Burkholderia pseudomallei (Q33200347) (← links)
- A simple scoring system to differentiate between relapse and re-infection in patients with recurrent melioidosis (Q33380206) (← links)
- Comparison of the in vitro and in vivo susceptibilities of Burkholderia mallei to Ceftazidime and Levofloxacin. (Q33441941) (← links)
- Exploring the HME and HAE1 efflux systems in the genus Burkholderia (Q33595044) (← links)
- Identification of Burkholderia mallei and Burkholderia pseudomallei adhesins for human respiratory epithelial cells (Q33709714) (← links)
- Functional characterization of OXA-57, a class D beta-lactamase from Burkholderia pseudomallei (Q33721955) (← links)
- Present and future therapeutic strategies for melioidosis and glanders (Q33797791) (← links)
- Recent advances in the treatment of severe melioidosis (Q33837723) (← links)
- In vitro susceptibilities of Burkholderia mallei in comparison to those of other pathogenic Burkholderia spp. (Q33978114) (← links)
- Cytokine gene expression in innately susceptible BALB/c mice and relatively resistant C57BL/6 mice during infection with virulent Burkholderia pseudomallei (Q34003899) (← links)
- Characterization of ceftazidime resistance mechanisms in clinical isolates of Burkholderia pseudomallei from Australia (Q34170246) (← links)
- Polysaccharide specific monoclonal antibodies provide passive protection against intranasal challenge with Burkholderia pseudomallei (Q34243707) (← links)
- Twelve positions in a β-lactamase that can expand its substrate spectrum with a single amino acid substitution (Q34282016) (← links)
- Oral fluoroquinolones for maintenance treatment of melioidosis (Q34456128) (← links)
- Treatment and prophylaxis of melioidosis (Q34538191) (← links)
- Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents (Q34552243) (← links)
- Interplay between three RND efflux pumps in doxycycline-selected strains of Burkholderia thailandensis (Q35080818) (← links)
- Functional characterization and evaluation of in vitro protective efficacy of murine monoclonal antibodies BURK24 and BURK37 against Burkholderia pseudomallei (Q35116418) (← links)
- Development of vaccines against burkholderia pseudomallei (Q35234118) (← links)
- Antimicrobial resistance to ceftazidime involving loss of penicillin-binding protein 3 in Burkholderia pseudomallei (Q35345951) (← links)
- Cloning, purification and crystallographic analysis of a hypothetical protein, BPSL1549, from Burkholderia pseudomallei (Q35596635) (← links)
- Passive protection of diabetic rats with antisera specific for the polysaccharide portion of the lipopolysaccharide isolated from Pseudomonas pseudomallei (Q35650030) (← links)
- Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis (Q36053937) (← links)
- Experimental Phage Therapy for Burkholderia pseudomallei Infection (Q36069790) (← links)
- Pseudomonas pseudomallei, a common pathogen in Thailand that is resistant to the bactericidal effects of many antibiotics (Q36753084) (← links)
- Mechanisms of antibiotic resistance in Burkholderia pseudomallei: implications for treatment of melioidosis (Q38066577) (← links)
- Survey of antimicrobial resistance in clinical Burkholderia pseudomallei isolates over two decades in Northeast Thailand (Q38726640) (← links)
- Immunisation with proteins expressed during chronic murine melioidosis provides enhanced protection against disease (Q38937699) (← links)
- Pulmonary Melioidosis (Q39094802) (← links)
- Calprotectin as a Biomarker for Melioidosis Disease Progression and Management. (Q39295421) (← links)
- A comparison of antibiotic susceptibility testing methods for cotrimoxazole with Burkholderia pseudomallei. (Q39356268) (← links)
- Variations in ceftazidime and amoxicillin-clavulanate susceptibilities within a clonal infection of Burkholderia pseudomallei. (Q39426298) (← links)
- Postantibiotic effects and Burkholderia (Pseudomonas) pseudomallei: evaluation of current treatment (Q39571043) (← links)
- Loss of Methyltransferase Function and Increased Efflux Activity Leads to Doxycycline Resistance in Burkholderia pseudomallei (Q39582866) (← links)
- Blood culture techniques for the diagnosis of melioidosis (Q39606155) (← links)
- Short-term topical therapy of experimental tinea pedis in guinea pigs with lanoconazole, a new imidazole antimycotic agent (Q39780685) (← links)
- Burkholderia pseudomallei and melioidosis: be aware in temperate area (Q40385900) (← links)
- Melioidosis masquerading as enteric fever (Q40399635) (← links)
- Cefixime. A review of its therapeutic efficacy in lower respiratory tract infections. (Q40463584) (← links)
- Cefetamet pivoxil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. (Q40487166) (← links)